Pfizer’s HighCon factory
Pfizer’s HighCon factory stands for the efficient, reliable production and packaging of innovative medicines for the global market — including a newly approved treatment option for COVID-19.
With an investment volume of close to 300 million euros, Pfizer has — within three years — expanded the existing plant into one of the world’s most modern production facilities for the pharmaceutical industry, fully in line with Industry 4.0.
Up to seven billion of solid tablets and capsules can be produced annually on…
